Dacula, Hamima .

HRN: 27-98-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2025
CEFTAZIDIME 1GM (VIAL)
10/28/2025
11/04/2025
IV
160mg
Q8
Neonatal Penumonia T/c Sepsis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: